Product: Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA  92037, NDC 51267-890-99.
Reason for recall: Defective Container: Customer complaints of punctures in the bottle.
Recall initiated: 20180809
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated